ASCO Daily News

134 Épisodes

1. Day 4: Top Takeaways From ASCO24

   Publié: 03/06/2024
2. Day 3: Top Takeaways From ASCO24    

   Publié: 02/06/2024
3. Day 2: Top Takeaways From ASCO24

   Publié: 01/06/2024
4. Day 1: Top Takeaways From ASCO24  

   Publié: 31/05/2024
5. Exploring CAR T Cells in GI Cancers at ASCO24

   Publié: 25/05/2024
6. Key Abstracts in GU Cancers at ASCO24

   Publié: 25/05/2024
7. ASCO24: The Future of Personalized Immunotherapy

   Publié: 24/05/2024
8. Novel Approaches in Hematologic Malignancies at ASCO24

   Publié: 24/05/2024
9. Spotlight on Breast Cancer at ASCO24

   Publié: 23/05/2024
10. ASCO24: The Era of the ADCs in NSCLC

    Publié: 23/05/2024
11. Optimizing Novel Therapies and Surgery in Early-Stage NSCLC

    Publié: 25/04/2024
12. A Revolution in Immunotherapy for Cervical and Endometrial Cancers

    Publié: 18/04/2024
13. How ctDNA Is Advancing Care for Patients With GI Cancers

    Publié: 04/04/2024
14. New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

    Publié: 21/03/2024
15. Innovations in CAR T-Cell Therapy for Multiple Myeloma

    Publié: 07/03/2024
16. ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity

    Publié: 15/02/2024
17. Advances in Precision Oncology for GI Cancers at GI24

    Publié: 08/02/2024
18. Key Advances in Prostate, Kidney, and Bladder Cancers at GU24

    Publié: 06/02/2024
19. What’s New in Prostate Cancer, RCC, and mUC at GU24

    Publié: 22/01/2024
20. Celebrating 20 Years of Evolution in GU Oncology

    Publié: 14/12/2023